COX-2 (human) Blocking Peptide 360107 from Cayman Chemical

Product Specs
ItemCOX-2 (human) Blocking Peptide
CompanyCayman Chemical
Price $146.00Supplier Page View Company Product Page
Catalog Number360107
Size200 µg
Specieshuman
Research AreaCyclooxygenase Pathway, Immunology & Inflammation, Inflammatory Lipid Mediators, Lipid Biochemistry, Prostaglandins
FormatA lyophilized peptide
Storage-20
OriginUSA

Add to Compare List

Cayman Chemical

Cayman Chemical Company 1180 East Ellsworth Road

Ann Arbor, Michigan 48108

United States

Phone: (800) 364-9897
(734) 971-3640

Company Profile

Website: http://www.caymanchem.com/

(1) Role of Noradrenaline and Adrenoreceptors in Regulating Prostaglandin E2 Synthesis Cascade in Inflamed Endometrium of PigsInternational journal of molecular sciencesMarch 20, 2023Jana B, Całka J, Bulc M, Witek K.specificity of rabbit anti-PTGS-2 and anti-mPTGES-1 antibodies, specific binding peptides were used (cat. no. 360107, cat. no. 360140, respectively, both from Cayman Chemical Co.) as a negative control. After the neutralization

(2) Stromal, rather than epithelial cyclooxygenase-2 (COX-2) expression is associated with overall survival of breast cancer patientsBMC cancerSeptember 30, 2014Urban J, Kuźbicki Ł, Szatkowski G, Stanek-Widera A, Lange D, Chwirot BW.Appropriate mixtures of the antibodies and of the corresponding blocking peptides (Ab2 – Cayman Chemical, 360107; Ab3 – Santa Cruz Biotechnology, (N20) P, sc-1746 P), prepared according to the manufacturer’s instruction,

(3) COX-2 expression does not correlate with microvessel density in breast cancerPathobiology : journal of immunopathology, molecular and cellular biologyJanuary 1, 2009Thorat MA, Mehrotra S, Morimiya A, Badve S.Laboratories, Burlingame, Calif., USA) counterstain. Specificity of the staining was verified by using 360107 COX-2 (human) blocking peptide (Cayman Chemical). Immunohistochemical Staining for CD31 Antigen retrieval

(4) Prognostic significance of cyclooxygenase-2 (COX-2) expression in patients with surgically resectable adenocarcinoma of the oesophagusBMC CancerDecember 1, 2006Pradeep Bhandari, Adrian C Bateman, Raj L Mehta, Bernard SF Stacey, Penny Johnson, Ian A Cree, Federica Di Nicolantonio, Praful Patelcells. The primary antibody to COX-2 (Cat. No. 160112) and the blocking peptide for COX-2 (Cat.No. 360107) were sourced from Cayman Chemical Company (Ann Arbor, Michigan, USA). Reproducibility and scoring validation During

(5) COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situBritish Journal of CancerJanuary 26, 2004G P Boland, I S Butt, R Prasad, W F Knox, N J Bundredserum was applied. A specific COX-2 blocking peptide (Cayman Chemical Company, Ann Arbor, MI, USA, 360107) was used as a negative control in 50 DCIS sections stained with the Cayman anti-COX-2 antibody (160112)

(6) Cyclooxygenase-2 Expression in Bladder Cancer: Correlation with Poor Outcome after ChemotherapyEuropean UrologyAugust 13, 2003Christian Wülfing, Elke Eltze, Dagmar von Struensee, Pia Wülfing, Lothar Hertle, Hansjürgen Piechota

(7) Downregulation of neuronal cyclooxygenase-2 expression in end stage Alzheimer’s diseaseNeurobiology of AgingJuly 25, 2001Anna V Yermakova, M Kerry O’Banion

Be the First to Write a Review!

COX-2 (human) Blocking Peptide from Cayman Chemical

Description

Cayman Chemical

Citations (7)

Reviews

COX-2 (human) Blocking Peptide from Cayman Chemical

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map